MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
dismutase mimetics asset
$3,500K
Proceeds from the sale of
common stock and common...
$635K
Cash provided by
investing activities
$3,500K
Cash provided by
financing activities
$635K
Net decrease in cash
and cash...
-$1,914K
Canceled cashflow
$4,135K
Net loss
$149,049K
Share-based compensation
expense
$410K
Prepaid expenses and
other current assets
-$357K
Cash used in
operating activities
-$6,049K
Canceled cashflow
$149,816K
Gain on
extinguishment of debt
$151,049K
Gain on sale of
dismutase mimetics assets
$3,500K
Accounts payable
-$1,010K
Change in fair value of
warrants
-$294K
Accrued expenses
-$11K
Other assets
$1K
Back
Back
Cash Flow
source: myfinsight.com
GRTX
GRTX